How big pharma is preying on young girls

Last week, I reported on a new study that found women who received the Gardasil vaccine for the human papilloma virus (HPV) were more likely to become infected with certain higher-risk strains of the HPV virus compared to women who didn’t get the vaccine.

Given this new information about Gardasil’s risks, I wanted to take a moment to remind you about my other concerns regarding this vaccine…

Overall, I strongly oppose the practice of vaccinating young girls and boys against HPV. We always knew Gardasil — at best — could only protect women against four of the 80 HPV strains associated with cervical cancer. So it never fully protected anyone.

Plus, even one of the vaccine’s key developers has concerns about the HPV vaccine…

Putting young girls in harm’s way for no benefit

Back in May 2014, I told you about Dr. Diane Harper. She helped design and carry out the Phase II and Phase III safety and effectiveness studies to get Gardasil approved. She also authored many of the published scholarly papers about it.

But about five years ago, Dr. Harper began speaking out against Gardasil.

According to Dr. Harper, big pharma oversells the benefits of the HPV vaccine. She acknowledged the vaccine only protects against four strains of the virus. But her biggest concern about the vaccine is that we don’t know how long it’s effective against those four strains of HPV.

In a CBS interview, Dr. Harper said, “If we vaccinate 11-year-old girls, and the protection doesn’t last…we’ve put them at harm from side effects…for no benefit. The benefit to public health is nothing, there is no reduction in cervical cancers, they are just postponed, unless the protection lasts for 15 years, and over 70 percent of all sexually active females of all ages are vaccinated.”

Harper also explained that cervical cancer risk in the U.S. had already fallen to very low levels. So it’s very unlikely vaccination against HPV would affect cervical cancer rates in the U.S. at all. Much less cervical cancer death rates.

98 percent of HPV infections go away on their own

Approximately eight in 10 sexually active women will contract HPV at some point in their life. Typically, the virus presents no symptoms. And in 98 percent of cases, it eventually clears itself. In fact, 70 percent of all HPV infections resolve by themselves with one year. And fully 90 percent of them clear within two years.

The developers based the vaccine on the two percent of cases in which the body’s immune system doesn’t clear the virus.

Then, in an even smaller percentage of women, the virus may lead to the development of pre-cancerous cells that may ultimately go on to develop into cervical cancer. Of course, routine Pap smears will detect these pre-cancerous cells long before any cancer develops.

Nonetheless, big pharma continues to market these vaccines as ironclad protection against cervical cancer. But such a claim is purely hypothetical.

No evidence shows the HPV vaccine prevents cervical cancer from developing. Those studies were never done.

In fact, as I mentioned earlier, we only know for sure that the vaccine prevents women from contracting four of the 80 strains of HPV associated with cervical cancer. So, the chance this vaccine will actually prevent cervical cancer is astronomically small.

Plus, we haven’t even touched on the vaccine’s many serious risks.

Nearly 30,000 reports of adverse effects

From the evidence I’ve reviewed, the vaccine is not safe in children. In fact, the majority of the trials for Gardasil were performed on adolescents, ages 15 years and older. But now the government-industrial-medical complex shamelessly pushes the vaccine on innocent 9-year-old girls!

And that’s a flat-out crime.

As of December 13, 2013, the federal Vaccine Adverse Events Reporting System (VAERS) received a total of 29,918 reaction reports associated with Gardasil vaccinations. Including 140 deaths.

Of course, parents make these reports. And they have to overcome all the obstacles put into place that make reporting difficult. VAERS paperwork is unbelievably cumbersome — even compared to other tedious government paperwork.

Some of the serious side effects reported to VAERS included:

  • Guillain Barré Syndrome (made infamous by the government’s disastrous swine flu vaccine of the 1970s). It’s a paralysis lasting for years, often permanently, sometimes causing suffocation.
  • Lupus
  • Seizures
  • Blood clots
  • Encephalitis (inflammation of the brain)

The greater crime — many pediatricians don’t make parents aware of these risks.

It all reminds me of how mainstream medicine continues to push cholesterol-lowering statin drugs, which clearly don’t work as intended. Plus, they cause many serious and dangerous side effects.

Hypotheses in science are valuable. They are supposed to be rich fields for experimentation. But unproven hypotheses alone are not supposed to be rich fields for profits. The FDA should protect us against drugs and vaccines that “hypothetically” work.

I told you all about the vaccines you really do need — and those you really don’t — in last month’s issue of my Insiders’ Cures newsletter. If you’re already a newsletter subscriber, you can access that issue on my website, www.drmicozzi.com, with your username and password. If you’re not yet a subscriber, now is the perfect time to get started.

Sources:

  1. “HPV Vaccine—Questions & Answers for the Public” Centers for Disease Control and Prevention” Centers for disease control (www.cdc.gov) 11/13/2009
  2. “HPV and Cancer,” National Cancer Institute (www.cancer.gov) 3/5/2012
  3. “Cervical Cancer Statistics” Centers for Disease Control (www.cdc.gov) 12/20/2012
  4. “Merck: New Drugs Pending Approval or in Late Tests,”Sci-Tech Today (www.sci-tech-today.com) 5/7/2014
  5. “Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine,” Rev Obstet Gynecol. 2008 Winter; 1(1): 2–10
  6. “Human Papillomavirus (HPV),” National Vaccine Information Center (www.nvic.org)
  7. “HPV Vaccine: Debate Over Benefits, Marketing, and New Adverse Event Data,” Medscape (www.medscape.com) 8/18/2009
  8. “Gardasil Researcher Speaks Out,” CBS News (www.cbsnews.com) 8/19/2009

CLOSE
CLOSE